Viewing stories from August, 2013

26 August 2013
Starpharma annual report and full year financial results

Starpharma today released its annual report and financial results for the year ended 30 June 2013.

Financial Results

  • Net cash burn for the year $9.0M
  • Cash position at end of the year $33.8M
  • Reported loss $5.2M
Read More

14 August 2013
Starpharma presentation at Canaccord Genuity Annual Growth Conference

Starpharma has announced that Chief Executive Officer Dr Jackie Fairley will present at the Canaccord Genuity 33rd Annual Growth Conference in Boston on August 14.  The event brings together around 200 companies from diversified industry sectors, and selected from around the world based on their high growth potential.

Read More

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.